Lv1
78 积分 2023-11-07 加入
A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial
5个月前
已完结
Endovascular Treatment for Calcified Femoropopliteal Peripheral Artery Disease and Risk Factor Identification: Two Year Outcomes of the Evolusion Study
5个月前
已完结
Femoropopliteal Endovascular Intervention: A Review of the Current Landscape
6个月前
已完结
Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment
6个月前
已完结
Long‐Term Outcomes of Jetstream Atherectomy Combined With Ranger Drug‐Coated Balloon in Calcified Femoropopliteal Lesions: A Three‐Year Single‐Center Experience
9个月前
已完结
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, randomised controlled trial
9个月前
已完结
Drug-coated vs non-drug-coated devices for femoropopliteal artery interventions: long-term outcomes of the SAFE-PAD study
10个月前
已完结
Endovascular Treatment for Calcified Femoropopliteal Peripheral Artery Disease and Risk Factor Identification: Two Year Outcomes of the Evolusion Study
10个月前
已完结
Global Algorithm for the Endovascular Treatment of Chronic Femoropopliteal Lesions
1年前
已完结
Changing Clinical Indications for Femoropopliteal Revascularization From 2016 to 2023
1年前
已关闭
皖公网安备34019202002308
